Literature DB >> 19128530

The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder.

Marilyn Huckans1, Adriana Seelye, Tiffany Parcel, Lisa Mull, Jonathan Woodhouse, Danell Bjornson, Bret E Fuller, Jennifer M Loftis, Benjamin J Morasco, Anna W Sasaki, Daniel Storzbach, Peter Hauser.   

Abstract

The aim of the study was to determine whether infection with the hepatitis C virus (HCV) is associated with cognitive impairment beyond the effects of prevalent comorbidities and a history of substance use disorder (SUD). Adult veterans were recruited from the Portland Veterans Affairs Medical Center into three groups: (1) HCV+/SUD+ (n = 39), (2) HCV+/SUD- (n = 24), and (3) HCV-/SUD- (n = 56). SUD+ participants were in remission for > or =90 days, while SUD- participants had no history of SUD. Groups did not significantly differ in terms of rates of psychiatric or medical comorbidities. Procedures included clinical interviews, medical record reviews, and neuropsychological testing. Significant group differences were found in the domains of Verbal Memory, Auditory Attention, Speeded Visual Information Processing, and Reasoning/Mental Flexibility (p <or = .05). Post hoc comparisons indicated that HCV+/SUD- patients performed significantly worse than HCV-/SUD- controls on tests measuring verbal learning, auditory attention, and reasoning/mental flexibility, but only HCV+/SUD+ patients did worse than HCV-/SUD- controls on tests of speeded visual information processing. Results indicate that chronic HCV is associated with cognitive impairment in the absence of a history of SUD. The most robust deficits appear to be in verbal learning and reasoning/mental flexibility. (JINS, 2009, 15, 69-82.).

Entities:  

Mesh:

Year:  2009        PMID: 19128530      PMCID: PMC2990957          DOI: 10.1017/S1355617708090085

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  56 in total

1.  Substance Dependence Severity Scale: reliability and validity for ICD-10 substance use disorders.

Authors:  G M Miele; K M Carpenter; M S Cockerham; K D Trautman; J Blaine; D S Hasin
Journal:  Addict Behav       Date:  2001 Jul-Aug       Impact factor: 3.913

2.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  Neuropsychological impairment in patients with chronic hepatitis C.

Authors:  Robin C Hilsabeck; William Perry; Tarek I Hassanein
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

Review 4.  Frontal lobe changes in alcoholism: a review of the literature.

Authors:  H F Moselhy; G Georgiou; A Kahn
Journal:  Alcohol Alcohol       Date:  2001 Sep-Oct       Impact factor: 2.826

5.  Evidence for a cerebral effect of the hepatitis C virus.

Authors:  D M Forton; J M Allsop; J Main; G R Foster; H C Thomas; S D Taylor-Robinson
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

6.  Dual dependence: assessment of dependence upon alcohol and illicit drugs, and the relationship of alcohol dependence among drug misusers to patterns of drinking, illicit drug use and health problems.

Authors:  Michael Gossop; John Marsden; Duncan Stewart
Journal:  Addiction       Date:  2002-02       Impact factor: 6.526

7.  Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.

Authors:  M Pereda; J L Ayuso-Mateos; A Gómez Del Barrio; S Echevarria; M C Farinas; D García Palomo; J González Macias; J L Vázquez-Barquero
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

8.  Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid.

Authors:  Tomasz Laskus; Marek Radkowski; Agnieszka Bednarska; Jeffrey Wilkinson; Debra Adair; Marek Nowicki; Georgia B Nikolopoulou; Hugo Vargas; Jorge Rakela
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.

Authors:  Ashlee J Whitehead; Steven K Dobscha; Benjamin J Morasco; Samantha Ruimy; Cara Bussell; Peter Hauser
Journal:  J Pain Symptom Manage       Date:  2008-03-20       Impact factor: 3.612

10.  Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication.

Authors:  Marek Radkowski; Jeffrey Wilkinson; Marek Nowicki; Debra Adair; Hugo Vargas; Craig Ingui; Jorge Rakela; Tomasz Laskus
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

View more
  25 in total

1.  Selective neurocognitive deficits and poor life functioning are associated with significant depressive symptoms in alcoholism-HIV infection comorbidity.

Authors:  Stephanie A Sassoon; Margaret J Rosenbloom; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Psychiatry Res       Date:  2012-05-29       Impact factor: 3.222

2.  Imiquimod and interferon-alpha augment monocyte-mediated astrocyte secretion of MCP-1, IL-6 and IP-10 in a human co-culture system.

Authors:  Michael D Rizzo; Robert B Crawford; Anthony Bach; Sera Sermet; Andrea Amalfitano; Norbert E Kaminski
Journal:  J Neuroimmunol       Date:  2019-05-20       Impact factor: 3.478

3.  Intra-individual variability across neurocognitive domains in chronic hepatitis C infection: elevated dispersion is associated with serostatus and unemployment risk.

Authors:  Erin E Morgan; Steven Paul Woods; Alexandra Rooney; William Perry; Igor Grant; Scott L Letendre
Journal:  Clin Neuropsychol       Date:  2012-04-26       Impact factor: 3.535

4.  Psychiatric care of the patient with hepatitis C: a review of the literature.

Authors:  Muhamad Aly Rifai; Ondria C Gleason; Douha Sabouni
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

5.  Protective effects of higher cognitive reserve for neuropsychological and daily functioning among individuals infected with hepatitis C.

Authors:  Maiko Sakamoto; Steven Paul Woods; Michael Kolessar; Daniel Kriz; J Renee Anderson; Hannah Olavarria; Anna W Sasaki; Michael Chang; Kenneth D Flora; Jennifer M Loftis; Marilyn Huckans
Journal:  J Neurovirol       Date:  2013-09-10       Impact factor: 2.643

6.  S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder.

Authors:  Jennifer M Loftis; Juno Valerio; Jonathan Taylor; Elaine Huang; Rebekah Hudson; Patricia Taylor-Young; Michael Chang; Samuel B Ho; Eric Dieperink; Juan Luis Miranda; Peter Hauser
Journal:  Alcohol Clin Exp Res       Date:  2018-06-28       Impact factor: 3.455

Review 7.  Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Authors:  Jennifer M Loftis; Marilyn Huckans; Benjamin J Morasco
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

8.  Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV.

Authors:  Stephen Correia; Ronald Cohen; Assawin Gongvatana; Skye Ross; James Olchowski; Kathryn Devlin; Karen Tashima; Bradford Navia; Suzanne Delamonte
Journal:  J Neuroimmunol       Date:  2013-09-27       Impact factor: 3.478

Review 9.  Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Authors:  Salvatore Monaco; Sara Mariotto; Sergio Ferrari; Massimiliano Calabrese; Gianluigi Zanusso; Alberto Gajofatto; Domenico Sansonno; Franco Dammacco
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

10.  Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression.

Authors:  Lindsay T Michalovicz; Gregory W Konat
Journal:  Metab Brain Dis       Date:  2013-12-24       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.